Skip to main content
Message Font: Serif | Sans-Serif
No. of Recommendations: 5
The CDC has determined that COVID-19 is a serious public health threat—and older adults and people with serious chronic medical conditions, including diabetes, are at a higher risk of experiencing complications and getting very sick from it.

Here’s what you need to know:

People with diabetes are not more likely to get COVID-19 than the general population. The problem people with diabetes face is primarily a problem of worse outcomes, not greater chance of contracting the virus.

The Association was founded by 26 physicians when it got underway over seventy-five years ago. It remained an organization for health care professionals during its first 30 years. In 1970, the Association welcomed general members. And in the years since, it has grown to include a network of more than 1 million volunteers. Yet diabetes has proven a stubborn foe. To learn more and travel through some of the major milestones, click through this timeline of accomplishments celebrating discovery, innovation and progress.

Living with type 2 diabetes puts you at higher risk for heart disease and stroke. Knowing what steps to take may reduce your risk.

Top Four Questions to Ask Your Doctor:

1. What changes can I make to take care of my heart?
2. What can I do before my next appointment?
3. How will I know if the changes I’ve made are making a difference?
4. What resources can help me learn more?

Understanding diabetes is the first step towards living one’s best life – the importance of healthy eating, regular exercise, and managing your medication. The AARP Let's Be Well Diabetes Box gives those living with diabetes the practical tools to take the necessary steps and empowers them to take care of themselves – on their own terms.

The Food and Drug Administration (FDA) authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced hybrid closed loop technology.

For now, the algorithm can be used with Tandem’s t:slim X2™ insulin pump and Dexcom’s G6 continuous glucose monitor (CGM). Though this is not the first algorithm approved for an artificial pancreas system, it is the first algorithm authorized as an interoperable automated glycemic controller, which means the algorithm could be a component of any open protocol, or interoperable, artificial pancreas system. Formerly, there was only one FDA approved artificial pancreas system on the market: The Medtronic 670G, approved in 2016.

Diabetes can be life-changing, but with the right support and a positive mindset, you can stay in control. Here are 6 Tips for Diabetics From Diabetics:

It's a few minutes before services on a Sunday morning at Bethany United Methodist Church in West Jefferson, N.C. The handbell choir warms up and an acolyte lights candles. Church member Peggy Lynn Gibson walks in with her dog, a stout, cream-colored golden retriever named Rocky. The congregants greet Rocky like an old friend.

Gibson, a 67-year-old retired nurse, is one of more than a million Americans with Type 1 diabetes, a difficult-to-manage autoimmune disease. People with the disease face a constant struggle to control the amount of sugar in their bloodstream. If it gets too low, it can lead to seizures, loss of consciousness, or death.

And Rocky was there to help. He's a diabetic alert dog specially trained to smell dangerous changes in someone's blood sugar and alert them with a paw or a nudge before it becomes a medical emergency, and he was a gift from the church community. A chili lunch, a silent auction, even a concert by local musicians all helped with his $15,000 price tag.

According to a new study published in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), people who live with Type 1 Diabetes (T1D) in the United States right now, as well as those who will develop the disease over the next 10 years, will pay a collective $813 billion over their lifetimes in medical costs and in lost income and productivity costs, as compared to a similar group that does not have T1D.

On an individual level, this translates to nearly $500,000 per person over the course of a lifetime.

Researchers have converted human stem cells into insulin-producing cells and demonstrated in mice infused with such cells that blood sugar levels can be controlled and diabetes functionally cured for nine months. The findings, from researchers at Washington University School of Medicine in St. Louis, are published online Feb. 24 in the journal Nature Biotechnology.

When you have health needs due to a chronic condition like type 1 diabetes (T1D), having health insurance is critical in helping you manage and treat your condition. That’s why JDRF is committed to supporting you by providing tools to help you navigate healthcare and health insurance. We know that as someone affected by T1D, your time is precious. Our aim is to help you understand your coverage options, that way you spend time where it matters, on you and your family. In this toolkit, we’ll provide information on several key areas you’ll want to consider as you select and then use your health insurance plan.

Every day, we receive a flurry of questions from our type 1 diabetes (T1D) community about the coronavirus and what it means for those of us living with T1D. Throughout this pandemic, we will share the Top Ten Questions and responses from experts in the field.

We here at JDRF are not medical experts, but we do work with the nation’s top professionals in the field and are looking to them to help with your questions. Even so, these responses are not intended to be medical advice, for that—as always—you must consult your own personal physician.

Here at the American Diabetes Association (ADA), we know that insulin is life-sustaining for people with diabetes—in fact, about 7 million Americans rely on insulin to live. But what you may not know is how it’s regulated by the U.S. Food and Drug Administration (FDA)—and how that’s changing starting this week. Here’s what’s happening—and what it may mean for you, and for our fight for affordable insulin for all who need it.

All insulins on the market have officially been labeled as biologics by the FDA—paving the way for biosimilar and interchangeable insulins. This change will enable more competition in the insulin market, which could bring down the price for some people. Interchangeable insulins may have the most promise of driving down prices, since the ability to substitute a generic drug for the brand-name version at the pharmacy counter is a big factor in bringing down prices for traditional generic drugs.

Next year, Medicare Part D enrollees may see lower monthly costs for insulins. The Centers for Medicare and Medicaid Services (CMS) announced a new pilot project with insulin manufacturers and Part D plans that could offer insulin coverage for $35 per prescription each month—even during the deductible phase and the donut hole. Participating plans must cover one of each type of insulin (rapid-acting insulin, regular insulin, intermediate insulin; and long-acting insulin), if manufacturers of each type participate.

ADA’s Legal Advocacy team has new resources to help you navigate COVID-19. These include a FAQ for workers; a sample physician letter supporting requests for reasonable accommodations; a letter to employers; and a letter to detention centers.

Several federal government agencies that enforce anti-discrimination laws have released guidance documents. There are new laws passed by Congress to respond to the crisis. Schools are closed, businesses are shuttered, and everyone is on edge.

If you are concerned you are being treated unfairly because of your diabetes, contact us to seek help from our Legal Advocacy team by calling 1-800-DIABETES (800-342-2383) or by emailing

We know that you are probably following the spread of COVID-19, or coronavirus, closely. The World Health Organization (WHO) has made the assessment that COVID-19 can be characterized as a pandemic. We know you have questions. We have answers.

Who kind of feels guilty with what is going on, but in the middle of this mess after 22 months of not working, he finally landed a job that is providing healthcare benefits and am in the middle of transitioning from an exchange plan that basically said you're on your own to a new plan that will hopefully actually help him cover his maintenance costs...

Ticker Guide: The Walt Disney Company (DIS), Intuit (INTU), Live Nation (LYV), CME Group (CME), MongoDB (MDB), Trip Advisor (TRIP), Vivendi SA (VIVHY), Mimecast (MIME), Hain Celestial (HAIN), Royce Micro Capital Trust (RMT)
Disclaimer: This post is non-professional and should not be construed as direct, individual or accurate advice
Disassociation: The views and statements of this post are Fuskie's and are not intended to represent those of The Motley Fool or any other sane body
Disclosure: May own shares of some, many or all of the companies mentioned in this post (
Fool Code of Conduct:
Invitation: You are invited to interactively watch Motley Fool Live online television:
Call to Action: If you like this or any other post, Rec it. Better yet, reply to it. Even better, start your own thread. This is YOUR TMF Community!
Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.